Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus

Jacob A. Dillard(University of North Carolina at Chapel Hill), Mark T. Heise(University of North Carolina at Chapel Hill)

Nature Communications

May 3, 2024

10.1038/s41467-024-47450-x

Cited by 15

Related Papers

Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus

|Research Square|2023|0